AtonRa Partners’s Thermo Fisher Scientific TMO Stock Holding History

AtonRa Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$252K	Sell	475 -45	-9%	-$21.8K	0.5%	90
2023 Q3	$263K	Sell	520 -12	-2%	-$6.39K	0.55%	91
2023 Q2	$278K	Sell	532 -106	-17%	-$57.2K	0.43%	104
2023 Q1	$368K	Sell	638 -89	-12%	-$50.2K	0.54%	88
2022 Q4	$400K	Sell	727 -154	-17%	-$81.6K	0.51%	86
2022 Q3	$447K	Sell	881 -225	-20%	-$126K	0.44%	97
2022 Q2	$601K	Sell	1,106 -3,225	-74%	-$1.78M	0.55%	84
2022 Q1	$2.56M	Sell	4,331 -1,672	-28%	-$960K	1.39%	20
2021 Q4	$4M	Sell	6,003 -341	-5%	-$213K	1.39%	20
2021 Q3	$3.63M	Buy	6,344 +650	+11%	+$357K	1.21%	27
2021 Q2	$2.87M	Sell	5,694 -169	-3%	-$79.7K	1.05%	41
2021 Q1	$2.68M	Sell	5,863 -1,144	-16%	-$546K	1.19%	35
2020 Q4	$3.26M	Buy	+7,007	New	+$3.29M	1.6%	16

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AtonRa Partners's TMO Position: Q4 2023 in Review

AtonRa Partners reduced its Thermo Fisher Scientific (TMO) stake by 8.7% in Q4 2023, selling an estimated $21.8K and leaving 475 shares worth $252K. The position accounts for 0.5% of the portfolio, ranked #90.

AtonRa Partners first reported a position in TMO in Q4 2020 and has held it in 13 quarters since. The position peaked at $4M in Q4 2021. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

AtonRa Partners held 475 shares of Thermo Fisher Scientific worth $252K as of Q4 2023.
AtonRa Partners sold 45 Thermo Fisher Scientific shares in Q4 2023, an estimated $21.8K.
Thermo Fisher Scientific made up 0.5% of AtonRa Partners's portfolio in Q4 2023, its #90 holding.
AtonRa Partners first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 13 quarters since.
AtonRa Partners's Thermo Fisher Scientific position peaked at $4M in Q4 2021.
2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on AtonRa Partners's 13F filing for Q4 2023, filed 5 Feb 2024.